NEW YORK (GenomeWeb News) – Norwegian enzymes firm ArcticZymes and Swedish gene expression profiling company Tataa Biocenter today announced a mutual sales and distribution deal covering Europe.
The terms of the agreement calls for Tataa to sell ArcticZymes' heat-labile enzymes for use in contamination control through its sales channels. Tataa will also integrate ArcticZymes' products into its range of courses.
Additionally, ArcticZymes will launch two reference gene panels and the ValidPrime kits series from Tataa. The kits offer for the first time a "rational and economical tool" for determining DNA contamination level, the companies said.
Financial and other terms of the deal were not disclosed.